Literature DB >> 11134604

Roles of urokinase type plasminogen activator in a brain stab wound.

K Kataoka1, T Asai, M Taneda, S Ueshima, O Matsuo, R Kuroda, A Kawabata, P Carmeliet.   

Abstract

Urokinase type plasminogen activator (uPA) may influence brain pathophysiology after injury. We studied disruption of the blood-brain barrier (BBB) and changes in the vasculature after a brain stab wound in uPA-deficient, uPA receptor-deficient, and PA inhibitor-1 (PAI-1) deficient mice. The extravasation of immunoglobulin was greater in PAI-1 deficient mice; less pronounced in uPA-deficient mice; similar to controls in uPA receptor-deficient mice. Vasculatures in the wound proliferated in PAI-1 deficient mice. Our study shows that uPA affects BBB disruption. PA enhances angiogenesis after brain injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134604     DOI: 10.1016/s0006-8993(00)03042-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis.

Authors:  Ke-Min Chen; Jer-Yuh Liu; Shih-Chan Lai; Li-Sung Hsu; Hsiu-Hsiung Lee
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

Review 2.  Neuroimmune interaction in seizures and epilepsy: focusing on monocyte infiltration.

Authors:  Dale B Bosco; Dai-Shi Tian; Long-Jun Wu
Journal:  FEBS J       Date:  2020-06-15       Impact factor: 5.542

3.  Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption.

Authors:  Yao Yao; Stella E Tsirka
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

Review 4.  Monocyte chemoattractant protein-1 and the blood-brain barrier.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Cell Mol Life Sci       Date:  2013-09-20       Impact factor: 9.261

Review 5.  Coagulopathy in traumatic brain injury.

Authors:  Sherman C Stein; Douglas H Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.

Authors:  Edward Rustamzadeh; Daniel A Vallera; Deborah A Todhunter; Walter C Low; Angela Panoskaltsis-Mortari; Walter A Hall
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

Review 7.  Traumatic brain injury using mouse models.

Authors:  Yi Ping Zhang; Jun Cai; Lisa B E Shields; Naikui Liu; Xiao-Ming Xu; Christopher B Shields
Journal:  Transl Stroke Res       Date:  2014-02-05       Impact factor: 6.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.